WallStreetZenWallStreetZen

NASDAQ: RPHM
Reneo Pharmaceuticals Inc Stock Ownership - Who owns Reneo Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Reneo Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Ashley HallChief Development Officer2023-08-2815,625$6.28
$98.06kSell
Ashley HallChief Development Officer2023-08-2815,625$1.80
$28.13kBuy
Holdings A. Novo10% Owner2023-06-23100,000$7.10
$709.70kSell
Niall OdonnellDirector2023-05-08125,000$8.00
$1.00MBuy

1 of 1

RPHM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPHM insiders and whales buy or sell their stock.

RPHM Shareholders

What type of owners hold Reneo Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Nea Management Company LLC14.32%4,785,494$8.33MInstitution
New Enterprise Associates 15 LP14.32%4,785,494$8.33MInsider
Holdings A. Novo9.96%3,330,337$5.79MInsider
Tang Capital Management LLC9.96%3,330,000$5.79MInstitution
Carlyle Group Inc8.08%2,698,957$4.70MInstitution
Rivervest Venture Management LLC7.58%2,534,220$4.41MInstitution
Rivervest Venture Fund Iii LP7.21%2,409,220$4.19MInsider
Octagon Capital Advisors LP6.73%2,250,000$3.92MInstitution
Niall Odonnell6.55%2,188,713$3.81MInsider
Bali Muralidhar6.21%2,073,957$3.61MInsider

1 of 3

RPHM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPHM61.78%38.22%Net Buying
IMMX2.96%31.19%Net Buying
KRON44.51%42.51%Net BuyingNet Selling
EQ21.71%40.89%Net Buying
AVRO46.76%53.24%Net SellingNet Selling
View Top Biotech Stocks

Reneo Pharmaceuticals Stock Ownership FAQ

Who owns Reneo Pharmaceuticals?

Reneo Pharmaceuticals (NASDAQ: RPHM) is owned by 75.65% institutional shareholders, 46.79% Reneo Pharmaceuticals insiders, and 0.00% retail investors. New Enterprise Associates 15 LP is the largest individual Reneo Pharmaceuticals shareholder, owning 4.79M shares representing 14.32% of the company. New Enterprise Associates 15 LP's Reneo Pharmaceuticals shares are currently valued at $8.09M.

If you're new to stock investing, here's how to buy Reneo Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.